These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2661477)

  • 1. [Continuous subcutaneous desferrioxamine injection in primary idiopathic hemochromatosis with macrocytic anemia].
    Schneider C; Richter H; Fischer JL; Larcher W
    Internist (Berl); 1989 May; 30(5):335-7. PubMed ID: 2661477
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic results in the treatment of primary and secondary hemochromatoses with Desferal].
    Wöhler F
    Blut; 1967 Apr; 15(1):33-42. PubMed ID: 6025965
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term efficacy of subcutaneous administration of deferoxamine in patients with secondary hemochromatosis].
    Kobayashi M; Yano K; Fujisawa S
    Rinsho Ketsueki; 1996 Apr; 37(4):303-10. PubMed ID: 8847800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Megaloblastic anemia due to primary B 12 avitaminosis. Apropos of 2 personal cases].
    Orsini A; Perrimond H; Bernard P; Pierron H; Boyer G
    Pediatrie; 1967 Mar; 22(2):171-88. PubMed ID: 5614975
    [No Abstract]   [Full Text] [Related]  

  • 5. [Apropos of a new case of anemia due to specific malaborsorption of vitamin B 12 with proteinuria: study of the megaloblastic anemias of infants due to primary B 12 avitaminosis].
    Gorin R; Salama C; Guillien F
    Ann Pediatr (Paris); 1967 May; 14(5):1383-97. PubMed ID: 4898275
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of desferrioxamine B and 2-(beta-aminoethoxy)cyclohexylaminetetraacetate in experimental hemochromatosis in rats and in primary hemochromatosis of man].
    Bohne F; Lessmann J
    Arzneimittelforschung; 1969 Jun; 19(6):944-7. PubMed ID: 5820039
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of desferrioxamine-induced sideruria and measurement of labile iron store as indices of body iron status.
    Singh AK
    J Med; 1971; 2(6):345-62. PubMed ID: 5292126
    [No Abstract]   [Full Text] [Related]  

  • 8. [RESEARCH ON DESFERRIOXAMINE B. 3. THE CLINICAL USE OF DESFERRIOXAMINE B].
    VENTURA S; COLI L
    Haematologica; 1964; 49():252-73. PubMed ID: 14217827
    [No Abstract]   [Full Text] [Related]  

  • 9. [Selective malabsorption of vitamin B12. Imerslung-Najman-Grasbeck anemia. Apropos of a case].
    Farriaux JP; Adam E; Swyngedauw J; Fontaine G
    Presse Med (1893); 1969 Sep; 77(40):1379-81. PubMed ID: 5821580
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of subcutaneous deferoxamine in a child with hemochromatosis associated with congenital dyserythropoietic anemia, type I.
    Smithson WA; Perrault J
    Mayo Clin Proc; 1982 May; 57(5):322-5. PubMed ID: 7078263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The diagnostic value of the desferrioxamine B test in the latent form of primary idiopathic hemochromatosis].
    Michaelis D; Takác A; Bruns W
    Acta Biol Med Ger; 1966; 16(3):300-8. PubMed ID: 4964937
    [No Abstract]   [Full Text] [Related]  

  • 12. [Megaloblastic anemia of pregnancy and puerperium caused by vitamin B 12 deficiency].
    de Lima GR; Kerbauy J; da Silva MP; Rocha RO
    Matern Infanc (Sao Paulo); 1969; 28(1):5-8. PubMed ID: 5380154
    [No Abstract]   [Full Text] [Related]  

  • 13. [Familial forms of megaloblastic anemias].
    Frick PG
    Schweiz Med Wochenschr; 1970 Nov; 100(46):1961-3. PubMed ID: 5507836
    [No Abstract]   [Full Text] [Related]  

  • 14. [Macrocytic anemia with anisocytosis due to alcohol abuse and vitamin B6 deficiency].
    Iwama H; Iwase O; Hayashi S; Nakano M; Toyama K
    Rinsho Ketsueki; 1998 Nov; 39(11):1127-30. PubMed ID: 9866426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital pernicious anemia: effects on growth, brain, and absorption of B12.
    McNicholl B; Egan B
    Pediatrics; 1968 Jul; 42(1):149-56. PubMed ID: 5657671
    [No Abstract]   [Full Text] [Related]  

  • 16. TREATMENT OF PRIMARY AND SECONDARY HEMOCHROMATOSIS AND ACUTE IRON POISONING WITH A NEW POTENT IRON ELIMINATING AGENT (DESFERRIOXAMINE B-DFOM).
    MOESCHLIN S; SCHNIDER U
    Ned Tijdschr Geneeskd; 1964 Aug; 108():1648-53. PubMed ID: 14222009
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term intraperitoneal deferoxamine for hemochromatosis.
    Swartz RD; Legault DJ
    Am J Med; 1996 Mar; 100(3):308-12. PubMed ID: 8629676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selective malabsorption of vitamin B 12 ].
    Furuhjelm U; Nevanlinna HR
    Duodecim; 1972; 88(1):92-6. PubMed ID: 5013581
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vitamin B12 deficiency in megaloblastic anemia in vegans].
    Heyman SN; Tobi M; Shalev O
    Harefuah; 1982 Oct; 103(7-8):148-50. PubMed ID: 7166269
    [No Abstract]   [Full Text] [Related]  

  • 20. [Continuous subcutaneous desferrioxamine infusions in patients with hemosiderosis (author's transl)].
    Tillmann W; König R; Schröder K; Schröter W
    Monatsschr Kinderheilkd; 1982 Mar; 130(3):171-2. PubMed ID: 7087975
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.